We are international
Donate
• myeloma tv TEXT SIZE   
webcasts from medical meetings    back

Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed/Refractory CD56-Positive Myeloma
By Asher A. Chanan-Khan, MD
12.18.06
Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed/Refractory CD56-Positive Myeloma



 related articles